Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors

HIV-1 integrase is the third enzymatic target of antiretroviral (ARV) therapy. However, few data have been published on the distribution of naturally occurring amino acid variation in this enzyme. We therefore characterized the distribution of integrase variants among more than 1,800 published group...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Soo-Yon, Liu, Tommy F, Kiuchi, Mark, Zioni, Rafael, Gifford, Robert J, Holmes, Susan P, Shafer, Robert W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546438/
https://www.ncbi.nlm.nih.gov/pubmed/18687142
http://dx.doi.org/10.1186/1742-4690-5-74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546438/
https://www.ncbi.nlm.nih.gov/pubmed/18687142
http://dx.doi.org/10.1186/1742-4690-5-74

Ejemplares similares